Patents
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
08/2012
08/09/2012US20120202226 method and system for the detection of cancer
08/09/2012US20120202225 Methods and devices for immunodiagnostic applications
08/09/2012US20120202224 Polypeptide variants with altered effector function
08/09/2012US20120202223 Ki-67 ASSAY FOR PATIENT IMMUNE SYSTEM STATUS
08/09/2012US20120202222 Enzyme fragment complementation assays for monitoring the activation of the voltage-gated potassium ion channel herg
08/09/2012US20120202220 Multivalent fluorescent probes
08/09/2012US20120202219 Psa capture agents, compositions, methods and preparation thereof
08/09/2012US20120202218 Detection method and device based on nanoparticle aggregation
08/09/2012US20120202217 Autoantibody enhanced immunoassays and kits
08/09/2012US20120202216 Novel photoactivable fluorescent dyes for optical microscopy and imaging techniques
08/09/2012US20120202215 Mitochondrial function of prohibitin 2 (phb2)
08/09/2012US20120202214 Method for detecting fusion gene
08/09/2012US20120202209 Cell imaging method for viewing microrna biogenesis in the cells
08/09/2012US20120202208 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
08/09/2012US20120202207 Genetic alterations in isocitrate dehydrogenase and other genes in malignant glioma
08/09/2012US20120202206 Pharmaceutical compositions and methods useful for modulating angiogenesis, inhibiting metastasis and tumor fibrosis, and assessing the malignancy of colon cancer tumors
08/09/2012US20120202200 Methods for detecting human papilloma virus-associated cancers
08/09/2012US20120202197 Efficient proliferation method for a kupffer cell and use thereof
08/09/2012US20120202195 Nucleic acid element for use in analysis, and analytical method, analytical reagent, and analytical instrument using same
08/09/2012US20120202194 Substance determining apparatus
08/09/2012US20120201840 EphA2 T-Cell Epitopes and Uses Therefor
08/09/2012US20120201838 Method for screening anticancer agent or sip1/zeb2 inhibitor using integrin alpha 5
08/09/2012US20120201837 Use of eif3m for the diagnosis and treatment of cancer
08/09/2012US20120201831 Human antibodies that bind human il-12 and methods for producing
08/09/2012US20120201829 Human Monoclonal Antibody Against S. Aureus Derived Alpha-Toxin and Its Use in Treating or Preventing Abscess Formation
08/09/2012US20120201824 Compositions and Methods for Inhibiting an Oncogenic Protein to Enhance Immunogenicity
08/09/2012US20120201810 Use of Anti-DKK-1 Monoclonal Antibodies for the Treatment of Liver Cancer
08/09/2012US20120201763 Novel flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
08/09/2012US20120201759 Tunable multiscale structures comprising bristly, hollow metal/metal oxide particles, methods of making and articles incorporating the structures
08/09/2012US20120201757 Mutant low-density lipoprotein receptor related protein with increased binding to alzheimer amyloid-beta peptide
08/09/2012US20120201752 Foxc1 antibodies and methods of their use
08/09/2012US20120201750 Serum biomarkers for melanoma metastasis
08/09/2012US20120201747 System and Method for Diagnosis and Treatment
08/09/2012US20120201721 Slide processing apparatus
08/09/2012US20120201720 Multiple Assay Device
08/09/2012US20120199539 Control of interface between separated blood components under lipemic and hemolytic conditions
08/09/2012US20120199499 Electronic methods for the detection of analytes
08/09/2012US20120199485 Ultra-fast nucleic acid sequencing device and a method for making and using the same
08/09/2012US20120199483 Nanopore capture system
08/09/2012US20120199480 Electrophoretic analysis method
08/09/2012US20120198949 Footcare product dispensing kiosk
08/09/2012US20120198922 Dual Analyzer System for Biological fluid
08/09/2012US20120198921 Process analysis unit
08/09/2012US20120198910 Breath Alcohol Analyser And A Method Of Determining Whether A Driver Is In A Condition To Drive
08/09/2012DE202012102769U1 Stechprobenträger in Form einer Mikroliterpipettenspitze für die Gewinnung und Sicherung von biologischem, medizinischem, veterinärmedizinischem, genetischem, forensischem und kriminalistischem Material Holly sample support in the form of a microliter pipette tip for the collection and preservation of biological, medical, veterinary medicine, genetic, forensic and criminological material
08/09/2012DE102004023262B4 Verfahren zur Bearbeitung einer Masse mittels Laserbestrahlung und Steuersystem A method for processing a mass by means of laser irradiation and control system
08/09/2012CA2837751A1 Functional foods and beverages with synergistic properties to promote homeostasis
08/09/2012CA2826657A1 Methods of using gene expression signatures to select a method of treatment, predict prognosis, survival, and/or predict response to treatment
08/09/2012CA2826579A1 Peptide library
08/09/2012CA2826144A1 Foxc1 antibodies and methods of their use
08/09/2012CA2825954A1 Use of galectin-3 for detecting and prognosing heart failure after acute coronary syndrome
08/09/2012CA2825894A1 Methods and compositions relating to inhibition of igf-1r
08/09/2012CA2825863A1 Wound prognosis
08/09/2012CA2825815A1 Methods for reducing nucleic acid damage
08/09/2012CA2825765A1 Anti-carbamylated protein antibodies and the risk for arthritis
08/09/2012CA2824361A1 Systems and methods for determining alumina properties
08/09/2012CA2766540A1 Methods, compositions and kits for the evaluation and preservation of sperm
08/08/2012EP2485053A1 Liquid reagent of thyroid hormone-immobilized carrier and use thereof
08/08/2012EP2485052A1 Encoded microparticles
08/08/2012EP2485051A1 Assay device
08/08/2012EP2485050A1 Use of micropatterned soft substrate for measuring of cell traction forces
08/08/2012EP2485049A2 Identification of separated components in centrifuged blood using measured pressure
08/08/2012EP2485048A1 Analysis device for blood sugar level with test element insertion guiding means
08/08/2012EP2485047A2 Methods and marker combinations for screening for predisposition to lung cancer
08/08/2012EP2485035A2 Vacuum assisted headspace microextraction sampling devices and methods
08/08/2012EP2484783A1 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
08/08/2012EP2484782A1 MicroRNA-based methods and compositions for the diagnosis and treatment of solid cancers
08/08/2012EP2484776A1 Heparin-insensitive method for determination of direct clotting factor inhibitors
08/08/2012EP2484775A1 Heparin-insensitive method for detecting direct clotting factor inhibitors
08/08/2012EP2484763A2 Neukinase, a downstream protein of neuregulin
08/08/2012EP2484752A2 Extracellular vesicles derived from gram-positive bacteria, and use thereof
08/08/2012EP2484751A2 Gradient structures interfacing microfluidics and nanofluidics, methods for fabrication and uses thereof
08/08/2012EP2484748A1 Nucleic acid analyzer
08/08/2012EP2484698A1 Hybridoma producing anti-methylated dna antibody and utilization of same
08/08/2012EP2484696A1 Antagonistic human light-specific human monoclonal antibodies
08/08/2012EP2484694A1 Monoclonal antibody against human hig-1 polypeptide
08/08/2012EP2484693A1 Human serum amyloid-a3 antibody and use thereof
08/08/2012EP2484692A1 Apolipoprotein a-1 mimic peptides, and therapeutic agent for treating hyperlipidemia and diseases related to hyperlipidemia comprising same
08/08/2012EP2484671A1 Fluorescent molecule and method for detecting target nucleic acid
08/08/2012EP2484630A1 Nanosensor for capturing charged molecules by using in situ stripping voltammetry
08/08/2012EP2484431A2 Nanofiber membrane for western blot and preparation method thereof
08/08/2012EP2483697A1 Serum-based biomarkers of pancreatic cancer and uses thereof for disease detection and diagnosis
08/08/2012EP2483696A1 Natural peptide and derivatives as modulators of gpcr gpr1 and uses thereof
08/08/2012EP2483695A2 Abnormal alterations of pkc isozymes processing in alzheimer's disease peripheral cells
08/08/2012EP2483694A1 Biomarkers for alzheimer's disease
08/08/2012EP2483693A1 A-fucosylation detection in antibodies
08/08/2012EP2483692A1 COMBINATION OF sPLA2 TYPE IIA MASS AND OXPL/APOB CARDIOVASCULAR RISK FACTORS FOR THE DIAGNOSIS/PROGNOSIS OF A CARDIOVASCULAR DISEASE/EVENT
08/08/2012EP2483691A1 Reductive amination and analysis of carbohydrates using 2-picoline borane as reducing agent
08/08/2012EP2483690A1 Marker sequences for pancreatic cancer diseases, pancreatic carcinoma and use thereof
08/08/2012EP2483689A2 Disposable device for the detection of particles of interest, such as biological entities, detection system comprising said device and method for using same
08/08/2012EP2483688A1 Method for characterization of biological bonds
08/08/2012EP2483687A1 Method leukemia diagnosis using caspase-3
08/08/2012EP2483686A1 Biomarkers for predicting the sensitivity and response of protein kinase ck2-mediated diseases to ck2 inhibitors
08/08/2012EP2483685A1 Method of calculating a phosphorus-protein ratio
08/08/2012EP2483684A1 Fibroblast growth patterns for diagnosis of alzheimer's disease
08/08/2012EP2483683A1 Method for preclinical testing of immunomodulatory drugs
08/08/2012EP2483682A1 Combination of spla2 activity and lp(a) cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event
08/08/2012EP2483681A1 Detection of markers in pressurized hydrocarbon fluids
08/08/2012EP2483680A1 Ultrafast sequencing of biological polymers using a labeled nanopore
08/08/2012EP2483674A2 Analyte sensor apparatuses having interference rejection membranes and methods for making and using them